11,814
Views
16
CrossRef citations to date
0
Altmetric
Review Articles

Gas Chromatography-Mass Spectrometry Analysis of Synthetic Opioids Belonging to the Fentanyl Class: A Review

ORCID Icon
Pages 1938-1968 | Published online: 30 May 2021

References

  • Grass, J. A. Sufentanil: Clinical Use as Postoperative Analgesic: Epidural/Intrathecal Route. J. Pain Symptom Manag. 1992, 7, 271–286. DOI: 10.1016/0885-3924(92)90061-L.
  • Grass, J. A. Fentanyl: Clinical Use as Postoperative Analgesic: Epidural/Intrathecal Route. J. Pain Symptom Manag. 1992, 7, 419–430. DOI: 10.1016/0885-3924(92)90022-A.
  • Buchanan, J. F.; Brown, C. R. ‘Designer Drugs’—A Problem in Clinical Toxicology. Med. Toxicol. Adverse Drug Exp. 1988, 3, 1–17. DOI: 10.1007/BF03259928.
  • Janssen, P. A. J.; Eddy, N. B. Compounds Related to Pethidine-IV. New General Chemical Methods of Increasing the Analgesic Activity of Pethidine. J. Med. Chem. 1960, 2, 31–45. DOI: 10.1021/jm50008a003.
  • Janssen, P. A. J.; Gardocki, J. F. Method for Producing Analgesia. US Patent 3141823, 1964.
  • Stanley, T. H. The History and Development of the Fentanyl Series. J. Pain Symp. Manag. 1992, 7, S3–S7. DOI: 10.1016/0885-3924(92)90047-L.
  • Janssen, P. A. J. A Review of the Chemical Features Associated with Strong Morphine-Like Activity. Br. J. Anaesth. 1962, 34, 260–268. DOI: 10.1093/bja/34.4.260.
  • Vardanyan, R. S.; Hruby, V. J. Fentanyl-Related Compounds and Derivatives: Current Status and Future Prospects for Pharmaceutical Applications. Future Med. Chem. 2014, 6, 385–412. DOI: 10.4155/fmc.13.215.
  • Armenian, P.; Vo, K. T.; Barr-Walker, J.; Lynch, K. L. Fentanyl, Fentanyl Analogs and Novel Synthetic Opioids: A Comprehensive Review. Neuropharmacology 2018, 134, 121–132. DOI: 10.1016/j.neuropharm.2017.10.016.
  • Chen, J.-C.; Smith, E. R.; Cahill, M.; Cohen, R.; Fishman, J. B. The Opioid Receptor Binding of Dezocine, Morphine, Fentanyl, Butorphanol and Nalbuphine. Life Sci. 1993, 52, 389–396. DOI: 10.1016/0024-3205(93)90152-s.
  • Pathan, H.; Williams, J. Basic Opioid Pharmacology: An Update. Br. J. Pain 2012, 6, 11–16. DOI: 10.1177/2049463712438493.
  • Shim, J.; Coop, A.; MacKerell, A. D. Jr. Molecular Details of the Activation of the m Opioid Receptor. J. Phys. Chem. B. 2013, 117, 7907–7917. DOI: 10.1021/jp404238n.
  • Pearson, A. Incapacitating Biochemical Weapons. Nonproliferation Rev. 2006, 13, 151–188. DOI: 10.1080/10736700601012029.
  • Ganesan, K.; Raza, S. K.; Vijayaraghavan, R. Chemical Warfare Agents. J. Pharm. Bioall. Sci. 2010, 2, 166–178. DOI: 10.4103/0975-7406.68498.
  • Duthie, D. J. R.; McLaren, A. D.; Nimmo, W. S. Pharmacokinetics of Fentanyl during Constant Rate i.v. infusion for the Relief of Pain after Surgery. Br. J. Anaesth. 1986, 58, 950–956. DOI: 10.1093/bja/58.9.950.
  • Kharasch, E. D. Opioid Half-Lives and Hemlines: The Long and Short of Fashion. Anesthesiology 2015, 122, 969–970. DOI: 10.1097/ALN.0000000000000634.
  • Centers for Disease Control and Prevention. Recommendations for Laboratory Testing for Acetyl Fentanyl and Patient Evaluation and Treatment for Overdose with Synthetic Opioid. CDC Health Alert Advisory, June 20, 2013. Health Alert Network, HAN00350.
  • Food and Drug Administration. FDA Advisory Committee on the Most Appropriate Dose or Doses of Naloxone to Reverse the Effects of Life-Threatening Opioid Overdose in the Community Settings. 2016. https://www.fda.gov/media/100409/download (accessed Oct 13, 2020).
  • Crabtree, B. L. Review of Naltrexone, a Long-Acting Opioid Antagonist. Clin. Pharm. 1984, 3, 273–280.
  • Gonzalez, J. P.; Brogden, R. N. N. A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Opioid Dependence. Drugs 1988, 35, 192–213. DOI: 10.2165/00003495-198835030-00002.
  • Kjome, K. L.; Moeller, F. G. Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence. Subst. Abuse 2011, 5, 1–9. DOI: 10.4137/SART.S5452.
  • Mayer, B. P.; Lau, E. Y.; Kennedy, D. J.; Valdez, C. A. Solution-State Structure and Affinities of Cyclodextrin:Fentanyl Complexes by Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics Simulation. J. Phys. Chem. B. 2016, 120, 2423–2433. DOI: 10.1021/acs.jpcb.5b12333.
  • Lynn, R. R.; Galinkin, J. L. Naloxone Dosage for Opioid Reversal: Current Evidence and Clinical Implications. Ther. Adv. Drug Saf. 2018, 9, 63–88. DOI: 10.1177/2042098617744161.
  • Chimbar, L.; Moleta, Y. Naloxone Effectiveness: A Systematic Review. J Addict. Nurs. 2018, 29, 167–171. DOI: 10.1097/JAN.0000000000000230.
  • Han, Y.; Yan, W.; Zheng, Y.; Khan, M. Z.; Yuan, K.; Li, L. The Rising Crisis of Illicit Fentanyl Use, Overdose, and Potential Therapeutic Strategies. Transl. Psychiat. 2019, 9, 282. DOI: 10.1038/s41398-019-0625-0.
  • Pardo, B.; Taylor, J.; Caulkins, J.; Reuter, P.; Kilmer, B. The Dawn of a New Synthetic Opioid Era: The Need for Innovative Interventions. Addiction 2020. DOI: 10.1111/add.15222.
  • France, C. P.; Ahern, G.; Averick, S.; Enright, H. A.; Esmaeli-Azad, B.; Federico, A.; Gerak, L. R.; Kolber, B.; Lau, E. Y.; Lao, V.; et al. Countermeasures for Preventing and Treating Opioid Overdose. Clin. Pharmacol. Ther. 2021, 109, 578–590. DOI: 10.1002/cpt.2098.
  • Wax, P. M.; Becker, C. E.; Curry, S. C. Unexpected “Gas” Casualties in Moscow: A Medical Toxicology Perspective. Ann. Emerg. Med. 2003, 41, 700–705. DOI: 10.1067/mem.2003.148.
  • Coupland, R. M. Incapacitating Chemical Weapons: A Year after the Moscow Theatre Siege. Lancet 2003, 362, 1346. DOI: 10.1016/S0140-6736(03)14684-3.
  • Stone, R. Weapons in Waiting. Science 2018, 359, 24–24. DOI: 10.1126/science.359.6371.24.
  • Riches, J. R.; Read, R. W.; Black, R. M.; Cooper, N. J.; Timperley, C. M. Analysis of Clothing and Urine from Moscow Theatre Siege Casual-Ties Reveals Carfentanil and Remifentanil Use. J. Anal. Toxicol. 2012, 36, 647–656. DOI: 10.1093/jat/bks07.
  • Algren, D. A.; Monteilh, C. P.; Punja, M.; Schier, J. G.; Belson, M.; Hepler, B. R.; Schmidt, C. J.; Miller, C. E.; Patel, M.; Paulozzi, L. J.; et al. Fentanyl-Associated Fatalities among Illicit Drug Users in Wayne County, Michigan (July 2005–May 2006). J. Med. Toxicol. 2013, 9, 106–115. DOI: 10.1007/s13181-012-0285-4.
  • Rodda, L. N.; Pilgrim, J. L.; Di Rago, M.; Crump, K.; Gerostamoulos, D.; Drummer, O. H. A Cluster of Fentanyl-Laced Heroin Deaths in 2015 in Melbourne. Australia. J. Anal. Toxicol. 2017, 41, 318–324. DOI: 10.1093/jat/bkx013.
  • Quintana, P.; Ventura, M.; Grifell, M.; Palma, A.; Galindo, L.; Fornís, I.; Gil, C.; Carbón, X.; Caudevilla, F.; Farré, M.; Torrens, M. The Hidden Web and the Fentanyl Problem: Detection of Ocfentanil as an Adulterant in Heroin. Int. J. Drug Policy 2017, 40, 78–83. DOI: 10.1016/j.drugpo.2016.10.006.
  • Gupta, P. K.; Ganesan, K.; Pande, A.; Malhotra, R. C. A Convenient One Pot Synthesis of Fentanyl. J. Chem. Res. 2005, 7, 452–453. DOI: 10.3184/030823405774309078.
  • Valdez, C. A.; Leif, R. N.; Mayer, B. P. An Efficient, Optimized Synthesis of Fentanyl and Related Analogs. PLoS One 2014, 9, e108250. DOI: 10.1371/journal.pone.0108250.
  • Walz, A. J.; Hsu, F.-L. An Operationally Simple Synthesis of Fentanyl Citrate. Org. Prep. Proced. Int 2017, 49, 467–470. DOI: 10.1080/00304948.2017.1374129.
  • Moss, R. B.; Carlo, D. J. Higher Doses of Naloxone Are Needed in the Synthetic Opioid Era. Subst. Abuse Treat. Prev. Policy 2019, 14, 1–6.
  • Yeung, D. T.; Bough, K. J.; Harper, J. R.; Platoff, G. E. Jr., National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)—August 6/7, 2019. J. Med. Toxicol. 2020, 16, 87–105. DOI: 10.1007/s13181-019-00750-x.
  • Kumar, K.; Morgan, D. J.; Crankshaw, D. P. Determination of Fentanyl and Alfentanil in Plasma by High-Performance Liquid Chromatography with Ultraviolet Detection. J Chromatogr 1987, 419, 464–468. DOI: 10.1016/0378-4347(87)80317-1.
  • Cooreman, S.; Deprez, C.; Martens, F.; Van Bocxlaer, J.; Croes, K. A Comprehensive LC-MS-Based Quantitative Analysis of Fentanyl-Like Drugs in Plasma and Urine. J. Sep. Sci. 2010, 33, 2654–2662. DOI: 10.1002/jssc.201000330.
  • Gerace, E.; Salomone, A.; Vincenti, M. Analytical Approaches in Fatal Intoxication Cases Involving New Synthetic Opioids. CPB 2018, 19, 113–123. DOI: 10.2174/1389201019666180405162734.
  • Valdez, C. A.; Leif, R. N.; Hok, S.; Hart, B. R. Analysis of Chemical War-Fare Agents by Gas Chromatography-Mass Spectrometry: Methods for Their Direct Detection and Derivatization Approaches for the Analysis of Their Degradation Products. Rev. Anal. Chem. 2018, 37, 1–26. DOI: 10.1515/revac-2017-0007.
  • Drummer, O. H. Fatalities Caused by Novel Opioids: A Review. Forensic Sci. Res. 2019, 4, 95–110. DOI: 10.1080/20961790.2018.1460063.
  • Schott, M.; Wehrenfennig, C.; Gasch, T.; Düring, R.-A.; Vilcinskas, A. A Portable Gas Chromatograph with Simultaneous Detection by Mass Spectrometry and Electroantennography for the Highly Sensitive in Situ Measurement of Volatiles. Anal. Bioanal. Chem. 2013, 405, 7457–7467. DOI: 10.1007/s00216-013-7196-3.
  • Leary, P. E.; Dobson, G. S.; Reffner, J. A. Development and Applications of Portable Gas Chromatography-Mass Spectrometry for Emergency Responders, the Military, and Law-Enforcement Organizations. Appl. Spectrosc. 2016, 70, 888–896. DOI: 10.1177/0003702816638294.
  • Leary, P. E.; Kammrath, B. W.; Lattman, K. J.; Beals, G. L. Deploying Portable Gas Chromatography-Mass Spectrometry (GC-MS) to Military Users for the Identification of Toxic Chemical Agents in Theater. Appl. Spectrosc. 2019, 73, 841–858. DOI: 10.1177/0003702819849499.
  • Pardo, B.; Taylor, J.; Caulkins, J. C.; Kilmer, B.; Reuter, P.; Stein, B. D. The Future of Fentanyl and Other Synthetic Opioids. Santa Monica, CA: RAND Corporation, 2019. DOI: 10.7249/RR3117.
  • Ruangyuttikarn, W.; Law, M. Y.; Rollins, D. E.; Moody, D. E. Detection of Fentanyl and Its Analogs by Enzyme-Linked Immunosorbent Assay. J. Anal. Toxicol. 1990, 14, 160–164. DOI: 10.1093/jat/14.3.160.
  • Alburges, M. E.; Hanson, G. R.; Gibb, J. W.; Sakashita, C. O.; Rollins, D. E. Fentanyl Receptor Assay. II. Utilization of a Radioreceptor Assay for the Analysis of Fentanyl Analogues in Urine. J. Anal. Toxicol. 1992, 16, 36–41. DOI: 10.1093/jat/16.1.36.
  • Wang, B. T.; Colby, J. M.; Wu, A. H. B.; Lynch, K. L. Cross-Reactivity of Acetylfentanyl and Risperidone with Fentanyl Immunoassay. J. Anal. Toxicol. 2014, 38, 672–675. DOI: 10.1093/jat/bku103.
  • Ogilvie, L.; Stanley, C.; Lewis, L.; Boyd, M.; Lozier, M. Notes from the Field: Acetyl Fentanyl Overdose fatalities-Rhode Island, March-May 2013. Morb. Mortal Wkly. Rep. 2013, 62, 703–704.
  • Schütz, H.; Paine, A.; Erdmann, F.; Weiler, G.; Verhoff, M. A. Immunoassays for Drug Screening in Urine: Chances, Challenges, and Pitfalls. Forensic Sci. Med. Pathol. 2006, 2, 75–83. DOI: 10.1385/FSMP:2:2:75.
  • Foerster, E. H.; Mason, M. F. Preliminary Studies on the Use of n-Butyl Chloride as an Extractant in a Drug Screening Procedure. J. Forensic Sci. 1974, 19, 10084J. DOI: 10.1520/JFS10084J.
  • Varvel, J. R.; Shafer, S. L.; Hwang, S. S.; Coen, P. A.; Stanski, D. R. Absorption Characteristics of Transdermally Administered Fentanyl. Anesthesiology 1989, 70, 928–934. DOI: 10.1097/00000542-198906000-00008.
  • Gardocki, J. F.; Yelnosky, J. A. Study of Some of the Pharmacological Activity of Fentanyl Citrate. Toxicol. Appl. Pharmacol. 1964, 6, 48–62. DOI: 10.1016/0041-008X(64)90021-3.
  • Janssen, P. A. J. Potent, New Analgesics, Tailor-Made for Different Purposes. Acta Anaesthesiol. Scand. 1982, 26, 262–268. DOI: 10.1111/j.1399-6576.1982.tb01765.x.
  • Gladden, R. M.; Martinez, P.; Seth, P. Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths—27 States, 2013-2014. MMWR Morb. Mortal. Wkly. Rep. 2016, 65, 837–843. DOI: 10.15585/mmwr.mm6533a2.
  • Marinetti, L. J.; Ehlers, B. J. A Series of Forensic Toxicology and Drug Seizure Cases Involving Illicit Fentanyl Alone and in Combination with Heroin, Cocaine or Heroin and Cocaine. J. Anal. Toxicol. 2014, 38, 592–598. DOI: 10.1093/jat/bku086.
  • Krinsky, C. S.; Lathrop, S. L.; Crossey, M.; Baker, G.; Zumwalt, R. A Toxicology-Based Review of Fentanyl-Related Deaths in New Mexico (1986-2007). Am. J. Forensic Med. Pathol. 2011, 32, 347–351. DOI: 10.1097/PAF.0b013e31822ad269.
  • Lee, D.; Chronister, C. W.; Broussard, W. A.; Utley-Bobak, S. R.; Schultz, D. L.; Vega, R. S.; Goldberger, B. A. Illicit Fentanyl-Related Fatalities in Florida: Toxicological Findings. J. Anal. Toxicol. 2016, 40, 588–594. DOI: 10.1093/jat/bkw087.
  • Peterson, A. B.; Gladden, R. M.; Delcher, C.; Spies, E.; Garcia-Williams, A.; Wang, Y.; Halpin, J.; Zibbell, J.; McCarty, C. L.; DeFiore-Hyrmer, J.; et al. Increases in Fentanyl-Related Overdose Deaths—Florida and Ohio, 2013-2015. MMWR Morb. Mortal. Wkly. Rep. 2016, 65, 844–849. DOI: 10.15585/mmwr.mm6533a3.
  • Blachman-Forshay, J.; Nolan, M. L.; McAteer, J. M.; Paone, D. Estimating the Risk of Exposure to Fentanyl in New York City: Testing Drug Residue in Used Syringes. Am. J. Public Health 2018, 108, 1666–1668. DOI: 10.2105/AJPH.2018.304694.
  • Mercado-Crespo, M. C.; Sumner, S. A.; Bridget Spelke, M.; Sugerman, D. E.; Stanley, C. Notes from the Field: Increase in Fentanyl-Related Overdose Deaths—Rhode Island, November 2013-March 2014. MMWR Morb. Mortal. Wkly. Rep. 2014, 63, 531.
  • Siegfried. Synthesis of Fentanyl. 2014. https://erowid.org/archive/rhodium/chemistry/fentanyl.html (accessed Oct 7, 2020).
  • Norman, K.; Ciesielski, A. L.; Wagner, J. R. Identification and Associated Hazards of Clandestine Drug Laboratories. WIREs Forensic Sci. 2021, 3, e1393. DOI: 10.1002/wfs2.1393.
  • Mayer, B. P.; DeHope, A. J.; Mew, D. A.; Spackman, P. E.; Williams, A. M. Chemical Attribution of Fentanyl Using Multivariate Statistical Analysis of Orthogonal Mass Spectral Data. Anal. Chem. 2016, 88, 4303–4310. DOI: 10.1021/acs.analchem.5b04434.
  • Mayer, B. P.; Valdez, C. A.; DeHope, A. J.; Spackman, P. E.; Williams, A. M. Statistical Analysis of the Chemical Attribution Signatures of 3-Methylfentanyl and Its Methods of Production. Talanta 2018, 186, 645–654. DOI: 10.1016/j.talanta.2018.02.026.
  • Mörén, L.; Qvarnström, J.; Engqvist, M.; Afshin-Sander, R.; Wu, X.; Dahlén, J.; Löfberg, C.; Larsson, A.; Östin, A. Attribution of Fentanyl Analogue Synthesis Route by Multivariable Data Analysis of Orthogonal Mass Spectral Data. Talanta 2019, 203, 122–130. DOI: 10.1016/j.talanta.2019.05.025.
  • Casale, J. F.; Hays, P.; Toske, S. G.; Mallette, J. R. Unique Bipiperidinyl Impurities Produced from the “One-Pot” Synthesis of Fentanyl. Forensic Chem. 2020, 17, 100203. DOI: 10.1016/j.forc.2019.100203.
  • Vaughan, S. R.; DeGreeff, L. E.; Forte, L.; Holness, H. K.; Furton, K. G. Identification of Volatile Components in the Headspace of Pharmaceutical-Grade Fentanyl. Forensic Chem. 2021, 24, 100331. DOI: 10.1016/j.forc.2021.100331.
  • Ovenden, S. P. B.; McDowall, L. J.; McKeown, H. E.; McGill, N. W.; Jones, O. A. H.; Pearson, J. R.; Petricevic, M.; Rogers, M. L.; Rook, T. J.; Williams, J.; et al. Investigating the Chemical Impurity Profiles of Fentanyl Preparations and Precursors to Identify Chemical Attribution Signatures for Synthetic Method Attribution. Forensic Sci. Int. 2021, 321, 110742. DOI: 10.1016/j.forsciint.2021.110742.
  • Vandeputte, M. M.; Krotulski, A. J.; Hulpia, F.; Calenbergh, V. S.; Stove, C. P. Phenethyl-4-ANPP: A Marginally Active Byproduct Suggesting a Switch in Illicit Fentanyl Synthesis Routes. J. Anal. Toxicol. 2021. DOI: 10.1093/jat/bkab032.
  • Fraga, C. G.; Bronk, K.; Dockendorff, B. P.; Heredia-Langner, A. Organic Chemical Attribution Signatures for the Sourcing of a Mustard Agent and Its Starting Materials. Anal. Chem. 2016, 88, 5406–5413. DOI: 10.1021/acs.analchem.6b00766.
  • Höjer Holmgren, K.; Valdez, C. A.; Magnusson, R.; Vu, A. K.; Lindberg, S.; Williams, A. M.; Alcaraz, A.; Åstot, C.; Hok, S.; Norlin, R. Part 1: Tracing Russian VX to Its Synthetic Routes by Multivariate Statistics of Chemical Attribution Signatures. Talanta 2018, 186, 586–596. DOI: 10.1016/j.talanta.2018.02.104.
  • Jansson, D.; Wiklund Lindström, S.; Norlin, R.; Hok, S.; Valdez, C. A.; Williams, A. M.; Alcaraz, A.; Nilsson, C.; Åstot, C. Part 2: Forensic Attribution Profiling of Russian VX in Food Using Liquid Chromatography-Mass Spectrometry. Talanta 2018, 186, 597–606. DOI: 10.1016/j.talanta.2018.02.103.
  • Williams, A. M.; Vu, A. K.; Jansson, D.; Mayer, B. P.; Hok, S.; Norlin, R.; Valdez, C. A.; Nilsson, C.; Åstot, C.; Alcaraz, A. Part 3: Solid Phase Extraction of Russian VX and Its Chemical Attribution Signatures in Food Matrices and Their Detection by GC-MS and LC-MS. Talanta 2018, 186, 607–614. DOI: 10.1016/j.talanta.2018.03.044.
  • Ovenden, S. P. B.; Webster, R. L.; Micich, E.; McDowall, L. J.; McGill, N. W.; Williams, J.; Zanatta, S. D. The Identification of Chemical Attribution Signatures of Stored VX Nerve Agents Using NMR, GC-MS and LC-HRMS. Talanta 2020, 211, 120753. DOI: 10.1016/j.talanta.2020.120753.
  • Lin, S. N.; Wang, T. F.; Caprioli, R. M.; Mo, B. P. Determination of Plasma Fentanyl by GC-Mass Spectrometry and Pharmacokinetic Analysis. J. Pharm. Sci. 1981, 70, 1276–1279. DOI: 10.1002/jps.2600701124.
  • Moore, J. M.; Allen, A. C.; Cooper, D. A.; Carr, S. M. Determination of Fentanyl and Related Compounds by Capillary Gas Chromatography with Electron Capture Detection. Anal. Chem. 1986, 58, 1656–1660. DOI: 10.1021/ac00121a013.
  • Watts, V.; Caplan, Y. Determination of Fentanyl in Whole Blood at Subnanogram Concentrations by Dual Capillary Column Gas Chromatography with Nitrogen Sensitive Detectors and Gas Chromatography/Mass Spectrometry. J. Anal. Toxicol. 1988, 12, 246–254. DOI: 10.1093/jat/12.5.246.
  • Laganière, S.; Goernert, L.; Gallicano, K.; Otson, R. Improved Extraction, Sensitivity, Specificity, and Stability for Measuring Fentanyl in Plasma by Gas Chromatography with Nitrogen Detection. Clin. Chem. 1993, 39, 2206–2207. DOI:10.1093/clinchem/39.10.2206.
  • Kingsbury, D. P.; Makowski, G. S.; Stone, J. A. Quantitative Analysis of Fentanyl in Pharmaceutical Preparations by Gas Chromatography-Mass Spectrometry. J. Anal. Toxicol. 1995, 19, 27–30. DOI: 10.1093/jat/19.1.27.
  • Sachs, H.; Uhl, M.; Hege-Scheuing, G.; Schneider, E. Analysis of Fentanyl and Sufentanil in Hair by GC/MS/MS. Int. J. Leg. Med. 1996, 109, 213–215. DOI: 10.1007/BF01225521.
  • Kronstrand, R.; Druid, H.; Holmgren, P.; Rajs, J. A Cluster of Fentanyl-Related Deaths among Drug Addicts in Sweden. Forensic Sci. Int. 1997, 88, 185–193. DOI: 10.1016/s0379-0738(97)00068-6.
  • Anderson, D. T.; Muto, J. J. Duragesic Transdermal Patch: postmortem Tissue Distribution of Fentanyl in 25 Cases. J. Anal. Toxicol. 2000, 24, 627–634. DOI: 10.1093/jat/24.7.627.
  • Kuhlman, J. J.; McCaulley, R.; Valouch, T. J.; Behonick, G. S. Fentanyl Use, Misuse, and Abuse: A Summary of 23 Post-Mortem Cases. J. Anal. Toxicol. 2003, 27, 499–504. DOI: 10.1093/jat/27.7.499.
  • Malkawi, A. H.; Al-Ghananeem, A. M.; Crooks, P. A. Development of a GC-MS Assay for the Determination of Fentanyl Pharmacokinetics in Rabbit Plasma after Sublingual Spray Delivery. AAPS J. 2008, 10, 261–267. DOI: 10.1208/s12248-008-9031-x.
  • Strano-Rossi, S.; Bermejo, A. M.; de la Torre, X.; Botrè, F. Fast GC-MS Method for the Simultaneous Screening of THC-COOH, Cocaine, Opiates and Analogues Including Buprenorphine and Fentanyl, and Their Metabolites in Urine. Anal. Bioanal. Chem. 2011, 399, 1623–1630. DOI: 10.1007/s00216-010-4471-4.
  • Moore, J. M.; Allen, A. C.; Cooper, D. A. Determination of Manufacturing Impurities in Heroin by Capillary Gas Chromatography with Electron Capture Detection after Derivatization with Heptafluorobutyric Anhydride. Anal. Chem. 1984, 56, 642–646. DOI: 10.1021/ac00268a012.
  • Strano-Rossi, S.; Alvarez, I.; Tabernero, M. J.; Cabarcos, P.; Fernández, P.; Bermejo, A. M. Determination of Fentanyl, Metabolite and Analogs in Urine by GC/MS. J. Appl. Toxicol. 2011, 31, 649–654. DOI: 10.1002/jat.1613.
  • Bravo, F.; González, D.; Benites, J. Development and Validation of a Solid-Phase Extraction Gas Chromatography-Mass Spectrometry Method for the Simultaneous Quantification of Opioid Drugs in Human Whole Blood and Plasma. J. Chil. Chem. Soc. 2011, 56, 799–802. DOI: 10.4067/S0717-97072011000300017.
  • McIntyre, I. M.; Gary, R. D.; Estrada, J.; Nelson, C. L. Antemortem and Postmortem Fentanyl Concentrations: A Case Report. Int. J. Legal Med. 2014, 128, 65–67. DOI: 10.1007/s00414-013-0897-5.
  • Gardner, M. A.; Sampsel, S.; Jenkins, W. W.; Owens, J. E. Analysis of Fentanyl in Urine by DLLME-GC-MS. J. Anal. Toxicol. 2015, 39, 118–125. DOI: 10.1093/jat/bku136.
  • Lozier, M. J.; Boyd, M.; Stanley, C.; Ogilvie, L.; King, E.; Martin, C.; Lewis, L. Acetyl Fentanyl, a Novel Fentanyl Analog, Causes 14 Overdose Deaths in Rhode Island, March–May 2013. J. Med. Toxicol. 2015, 11, 208–217. DOI: 10.1007/s13181-015-0477-9.
  • Higashikawa, Y.; Suzuki, S. Studies on 1-(2-Phenthyl)-4- (N-Propionylanilino)Piperidine (Fentanyl) and Its Related Compounds: structure-Analgesic Activity Relationship for Fentanyl, Methyl-Substituted Fentanyls and Other Analogues. Forensic Toxicol. 2008, 26, 1–5. DOI: 10.4155/fmc.13.215.
  • Janssen, P. A. J. 1-Aralkyl-4-(n-Aryl-Carbonyl Amino)-Piperidines and Related Compounds. US Patent 3164600, 1965.
  • Helander, A.; Bäckberg, M.; Beck, O. Intoxications Involving the Fentanyl Analogs Acetylfentanyl, 4-Methoxybutyrfentanyl and Furanylfentanyl: Results from the Swedish STRIDA Project. Clin. Toxicol. 2016, 54, 324–332. DOI: 10.3109/15563650.2016.1139715.
  • Dwyer, J. B.; Janssen, J.; Luckasevic, T. M.; Williams, K. E. Report of Increasing Overdose Deaths That Include Acetyl Fentanyl in Multiple Countries of the Southwestern Regions of Pennsylvania in 2015-2016. J. Forensic Sci. 2018, 63, 195–200. DOI: 10.1111/1556-4029.13517.
  • Katselou, M.; Papoutsis, I.; Nikolaou, P.; Spiliopoulou, C.; Athanaselis, S. Old Opioids, New Concerns: The Case of Acetylfentanyl. Forensic Toxicol. 2016, 34, 201–212. DOI: 10.1007/s11419-016-0310-4.
  • McIntyre, I. M.; Trochta, A.; Gary, R. D.; Malamatos, M.; Lucas, J. R. An Acute Acetyl Fentanyl Fatality: A Case Report with Postmortem Concentrations. J. Anal. Toxicol. 2015, 39, 490–494. DOI: 10.1093/jat/bkv043.
  • Fort, C.; Curtis, B.; Nichols, C.; Niblo, C. Acetyl Fentanyl Toxicity: Two Case Reports. J. Anal. Toxicol. 2016, 40, 754–757.
  • Cunningham, S. M.; Haikal, N. A.; Kraner, J. C. Fatal Intoxication with Acetyl Fentanyl. J. Forensic Sci. 2016, 61, S276–S280. DOI: 10.1111/1556-4029.12953.
  • Yonemitsu, K.; Sasao, A.; Mishima, S.; Ohtsu, Y.; Nishitani, Y. A Fatal Poisoning Case by Intravenous Injection of "Bath Salts" Containing Acetyl Fentanyl and 4-Methoxy PV8. Forensic Sci. Int. 2016, 267, e6–e9. DOI: 10.1016/j.forsciint.2016.08.025.
  • Takase, I.; Koizumi, T.; Fujimoto, I.; Yanai, A.; Fujimiya, T. An Autopsy Case of Acetyl Fentanyl Intoxication Caused by Insufflation of ‘Designer Drugs. Legal Med. 2016, 21, 38–44. DOI: 10.1016/j.legalmed.2016.05.006.
  • McIntyre, I. M.; Trochta, A.; Gary, R. D.; Wright, J.; Mena, O. An Acute Butyr-Fentanyl Fatality: A Case Report with Postmortem Concentrations. J. Anal. Toxicol. 2016, 40, 162–166. DOI: 10.1093/jat/bkv043.
  • Weldon, S. T.; Perry, D. F.; Cork, R. C.; Gandolfi, A. J. Detection of Picogram Levels of Sufentanil by Capillary Gas Chromatography. Anesthesiology 1985, 63, 684–687. DOI: 10.1097/00000542-198512000-00021.
  • Stevens, R. A.; Petty, R. H.; Hill, H. F.; Kao, T. C.; Schaffer, R.; Hahn, M. B.; Harris, P. Redistribution of Sufentanil to Cerebrospinal Fluid and Systemic Circulation after Epidural Administration in Dogs. Anesth. Analg. 1993, 76, 323–327.
  • Bjorksten, A. R.; Chan, C.; Crankshaw, D. P. Determination of Remifentanil in Human Blood by Capillary Gas Chromatography with Nitrogen-Selective Detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 775, 97–101. DOI: 10.1016/S1570-0232(02)00178-2.
  • Van Nimmen, N. F. J.; Poels, K. L. C.; Veulemans, H. A. F. Highly Sensitive Gas Chromatographic-Mass Spectrometric Screening Method for the Determination of Picogram Levels of Fentanyl, Sufentanil and Alfentanil and Their Major Metabolites in Urine of Opioid Exposed Workers. J. Chromatogr. B 2004, 804, 375–387. DOI: 10.1016/j.jchromb.2004.01.044.
  • Van Nimmen, N. F. J.; Veulemans, H. A. F. Development and Validation of a Highly Sensitive Gas Chromatographic-Mass Spectrometric Screening Method for the Simultaneous Determination of Nanogram Levels of Fentanyl, Sufentanil and Alfentanil in Air and Surface Contamination Wipes. J. Chromatogr. A 2004, 1035, 249–259. DOI: 10.1016/j.chroma.2004.02.074.
  • Sorokin, V. I.; Semkin, E. P.; Savilov, A. P. Expert Examination of 3-Methylfentanyl. Microgram 1994, 27, 221–226.
  • Poklis, J.; Poklis, A.; Wolf, C.; Hathaway, C.; Arbefeville, E.; Chrostowski, L.; Devers, K.; Hair, L.; Mainland, M.; Merves, M.; Pearson, J. Two Fatal Intoxications Involving Butyryl Fentanyl. J. Anal. Toxicol. 2016, 40, 703–708. DOI: 10.1093/jat/bkw048.
  • Staeheli, S. N.; Baumgartner, M. R.; Gauthier, S.; Gascho, D.; Jarmer, J.; Kraemer, T.; Steuer, A. E. Time-Dependent Postmortem Redistribution of Butyrfentanyl and Its Metabolites in Blood and Alternative Matrices in a Case of Butyrfentanyl Intoxication. Forensic Sci. Int. 2016, 266, 170–177. DOI: 10.1016/j.forsciint.2016.05.034.
  • Breindahl, T.; Kimergård, A.; Andreasen, M. F.; Pedersen, D. S. Identification of a New Psychoactive Substance in Seized Material: The Synthetic Opioid N-Phenyl-N-[1-(2-Phenethyl)Piperidin-4-yl]Prop-2-Enamide (Acrylfentanyl). Drug Test. Analysis 2017, 9, 415–422. DOI: 10.1002/dta.2046.
  • Swanson, D. M.; Hair, L. S.; Strauch Rivers, S. R.; Smyth, B. C.; Brogan, S. C.; Ventoso, A. D.; Vaccaro, S. L.; Pearson, J. M. Fatalities Involving Carfentanil and Furanyl Fentanyl: Two Case Reports. J. Anal. Toxicol. 2017, 41, 498–502. DOI: 10.1093/jat/bkx037.
  • Misailidi, N.; Athanaselis, S.; Nikolaou, P.; Katselou, M.; Dotsikas, Y.; Spiliopoulou, C.; Papoutsis, I. A GC–MS Method for the Determination of Furanylfentanyl and Ocfentanil in Whole Blood with Full Validation. Forensic Toxicol. 2019, 37, 238–244. DOI: 10.1007/s11419-018-0449-2.
  • Melent’ev, A. B.; Kataev, S. S.; Dvorskaya, O. N. Identification and Analytical Properties of Acetyl Fentanyl Metabolites. J. Anal. Toxicol. 2015, 70, 240–248.
  • George, A. V.; Lu, J. J.; Pisano, M. V.; Metz, J.; Erickson, T. B. Carfentanil—An Ultra Potent Opioid. Am. J. Emerg. Med. 2010, 28, 530–532. DOI: 10.1016/j.ajem.2010.03.003.
  • Haigh, J. C.; Lee, L. J.; Schweinsburg, R. E. Immobilization of Polar Bears with Carfentanil. J. Wildl. Dis. 1983, 19, 140–144. DOI: 10.7589/0090-3558-19.2.140.
  • Neumann, G.; Erhardt, W.; Oberhuber, B.; Fritsch, R.; Blumel, G. A New Highly Potent and Short-Acting Analgesic, Carfentanyl (R33799), in Combination with the Hypnotic Agent, Etomidat (r26490) as a Method of Anaesthesia in guinea Pigs. Res. Exp. Med. 1980, 177, 135–143. DOI: 10.1007/BF01851842.
  • Baker, J. R.; Gatesman, T. J. Use of Carfentanil and Ketamine-Xylazine Mixture to Immobilize Wild Great Seals (Halichoerus grypus). Vet. Rec. 1985, 116, 208–210. DOI: 10.1136/vr.116.8.208.
  • Weckmann, T. J.; Tai, C. L.; Woods, W. E.; Tai, H. H.; Blake, J. W.; Tobin, T. Pharmacological Effects and Detection Methods of Methylated Analogs of Fentanyl in Horses. Am. J. Vet. Res. 1989, 50, 502–507.
  • Shafer, S. L. Carfentanil: A Weapon of Mass Destruction. Can. J. Anesth. 2019, 66, 351–355. DOI: 10.1007/s12630-019-01295-x.
  • Waite, K.; Deeken, A.; Perch, S.; Kohler, L. J. Current Opioid Trends in Summit County, Ohio. Acad. Forensic Pathol. 2017, 7, 632–639. DOI: 10.23907/2017.053.
  • Zibbell, J. E.; Aldridge, A. P.; Cauchon, D.; DeFiore-Hyrmer, J.; Conway, K. P. Association of Law Enforcement Seizures of Heroin, Fentanyl and Carfentanil with Opioid Overdose Deaths in Ohio, 2014-2017. JAMA Netw. Open 2019, 2, e1914666. DOI: 10.1001/jamanetworkopen.2019.14666.
  • Cowles, C. E.; Jr., Mitchell, J.; Stepp, J. E.; Bewley, B. Z. Carfentanil: A New and Often Unrecognized Threat. J. Spec. Oper. Med. 2017, 17, 120–122.
  • Cole, J. B.; Nelson, L. S. Controversies and Carfentanil: We Have Much to Learn about the Present State of Opioid Poisoning. Am. J. Emerg. Med. 2017, 35, 1743–1745. DOI: 10.1016/j.ajem.2017.08.045.
  • Misailidi, N.; Papoutsis, I.; Nikolaou, P.; Dona, A.; Spiliopoulou, C.; Athanaselis, S. Fentanyls Continue to Replace Heroin in the Drug Arena: The Cases of Ocfentanil and Carfentanil. Forensic Toxicol. 2018, 36, 12–32. DOI: 10.1007/s11419-017-0379-4.
  • Enders, D.; Shilvock, J. P. Some Recent Applications of α-Amino Nitrile Chemistry. Chem. Soc. Rev. 2000, 29, 359–373. DOI: 10.1039/a908290e.
  • Taber, D. F.; Rahimizadeh, M. Amide to Ester Conversion: A Practical Route to the Carfentanil Class of Analgetics. J. Org. Chem. 1992, 57, 4037–4038. DOI: 10.1021/jo00040a061.
  • McClure, C. K.; Kiessling, A. J.; Banks, H. D. Synthesis of N-(1-benzyl)-4-Methoxycarbonyl-4-Piperidinyl-N-Phenylpropanamide. Edgewood Research, Development & Engineering Center, Aberdeen Proving Ground, MD. ERDEC-TR-070, May 1993.
  • Feldman, P. L.; Brackeen, M. F. A Novel Route to the 4-Anilido-4-(Methoxycarbonyl)Piperidine Class of Analgetics. J. Org. Chem. 1990, 55, 4207–4209. DOI: 10.1021/jo00300a047.
  • Malaquin, S.; Jida, M.; Gesquiere, J.-C.; Deprez-Poulain, R.; Deprez, B.; Laconde, G. Ugi Reaction for the Synthesis of 4-Aminopiperidine-4-Carboxylic Acid Derivatives. Application to the Synthesis of Carfentanil and Remifentanil. Tetrahedron Lett. 2010, 51, 2983–2985. DOI: 10.1016/j.tetlet.2010.03.120.
  • van Daele, P. G. H.; De Bruyn, M. F. L.; Boey, J. M.; Sanczuk, S.; Agten, J. T. M.; Janssen, P. A. J. Synthetic Analgesics: N-(1-[2-Arylethyl]-4-Substituted 4-Piperidinyl)-N-Arylalkanamides. Arznei-Forschung 1976, 26, 1521–1531. DOI: 10.1002/chin.197646236.
  • Niemegeers, C. J.; Schellekens, K. H.; van Bever, W. F.; Janssen, P. A. Sufentanil, a Very Potent and Extremely Safe Intravenous Morphine-Like Compound in Mice, Rats and Dogs. Arznei-Forschung 1976, 26, 1551–1556.
  • Monk, J. P.; Beresford, R.; Ward, A. S. A Review of Its Pharmacological Properties and Therapeutic Use. Drugs 1988, 36, 286–313. DOI: 10.2165/00003495-198836030-00003.
  • Leysen, J. E.; Gommeren, W.; Niemegeers, C. J. [3H]Sufentanil, a Superior Ligand for mu-Opiate Receptors: Binding Properties and Regional Distribution in Rat Brain and Spinal Cord. Eur. J. Pharmacol. 1983, 87, 209–225. DOI: 10.1016/0014-2999(83)90331-X.
  • Shin, D.-Y.; Ryu, J.-S.; Hyun, S.-S.; Park, H.-J.; Jeon, R.-O.; Suh, Y.-G. Total Synthesis of Sufentanil. Arch. Pharm. Res. 1999, 22, 398–400. DOI: 10.1007/BF02979064.
  • Corey, E. J.; Chaykovsky, M. Dimethyloxosulfonium Methylide ((CH3)2SOCH2) and Dimethylsulfonium Methylide ((CH3)2SCH2). Formation and Application to Organic Synthesis. J. Am. Chem. Soc. 1965, 87, 1353–1364. DOI: 10.1021/ja01084a03.
  • Gillespie, T. J.; Gandolfi, A. J.; Maiorino, R. M.; Vaughan, R. W. Gas Chromatographic Determination of Fentanyl and Its Analogues in Human Plasma. J. Anal. Toxicol. 1981, 5, 133–137. DOI: 10.1093/jat/5.3.133.
  • Ferslew, K. E.; Hagardorn, A. N.; McCormick, W. F. Postmortem Determination of the Biological Distribution of Sufentanil and Midazolam after an Acute Intoxication. J. Forensic Sci. 1989, 34, 12630J. DOI: 10.1520/JFS12630J.
  • Bennion, B. J.; Be, N. A.; McNerney, M. W.; Lao, V.; Carlson, E. M.; Valdez, C. A.; Malfatti, M. A.; Enright, H. A.; Nguyen, T. H.; Lightstone, F. C.; Carpenter, T. S. Predicting a Drug’s Membrane Permeability: A Computational Model Validated with in Vitro Permeability Assay Data. J. Phys. Chem. B. 2017, 121, 5228–5237. DOI: 10.1021/acs.jpcb.7b02914.
  • Koyyalagunta, D. Chapter 113—Opioid Analgesics. Pain Manag. 2007, 2, 939–964. DOI: 10.1016/B978-0-7216-0334-6.50117-5.
  • Wandel, C.; Kim, R.; Wood, M.; Wood, A. Interaction of Morphine, Fentanyl, Sufentanil, Alfentanil, and Loperamide with the Efflux Drug Transporter P-Glycoprotein. Anesthesiology 2002, 96, 913–920. DOI: 10.1097/00000542-200204000-00019.
  • Ujváry, I.; Jorge, R.; Christie, R.; Le Ruez, T.; Danielsson, H. V.; Kronstrand, R.; Elliott, S.; Gallegos, A.; Sedefov, R.; Evans-Brown, M. Acryloylfentanyl, a Recently Emerged New Psychoactive Substance: A Comprehensive Review. Forensic Toxicol. 2017, 35, 232–243. DOI: 10.1007/s11419-017-0367-8.
  • Maryanoff, B. E.; Simon, E. J.; Gioannini, T.; Gorissen, H. Potential Affinity Labels for the Opiate Receptor Based on Fentanyl and Related Compounds. J. Med. Chem. 1982, 25, 913–919. DOI: 10.1021/jm00350a006.
  • Pierzynski, H. G.; Neubauer, L.; Choi, C.; Franckowski, R.; Augustin, S. D.; Iula, D. M. Tips for Interpreting GC-MS Fragmentation of Unknown Substituted Fentanyls. Cayman Curr. 2017, 28, 1–3.
  • Valdez, C. A.; Leif, R. N.; Hok, S.; Alcaraz, A. Assessing the Reliability of the NIST Library during Routine GC-MS Analyses: Structure and Spectral Data Corroboration for 5,5-Diphenyl-1,3-Dioxolan-4-One during a Recent OPCW Proficiency Test. J. Mass Spectrom. 2018, 53, 419–422. DOI: 10.1002/jms.4073.
  • Moorthy, A. S.; Kearsley, A. J.; Mallard, W. G.; Wallace, W. E. Mass Spectral Similarity Mapping Applied to Fentanyl Analogs. Forensic Chem. 2020, 19, 100237. DOI: 10.1016/j.forc.2020.100237.
  • Guerrieri, D.; Rapp, E.; Roman, M.; Thelander, G.; Kronstrand, R. Acrylfentanyl: another New Psychoactive Drug with Fatal Consequences. Forensic Sci. Int 2017, 277, e21–e29. DOI: 10.1016/j.forsciint.2017.05.010.
  • UNODC. Recommended Methods for the Identification and Analysis of Fentanyl and Its Analogues in Biological Specimens. United Nations Office on Drugs and Crime, Vienna, 2017. DOI: 10.18356/aca7aca5-en.
  • Bäckberg, M.; Beck, O.; Jönsson, K.-H.; Helander, A. Opioid Intoxications Involving Butyrfentanyl, 4-Fluorobutyrfentanyl, and Fentanyl from the Swedish STRIDA Project. Clin. Toxicol. 2015, 53, 609–615. DOI: 10.3109/15563650.2015.1054505.
  • Cole, J. B.; Dunbar, J. F.; McIntire, S. A.; Regelmann, W. E.; Slusher, T. M. Butyrfentanyl Overdose Resulting in Diffuse Alveolar Hemorrhage. Pediatrics 2015, 135, e740–e743. DOI: 10.1542/peds.2014-2878.
  • Bürkle, H.; Dunbar, S.; Van Aken, H. Remifentanil: A Novel, Short-Acting, Mu-Opioid. Anesth. Analg. 1996, 83, 646–651. DOI: 10.1097/00000539-199609000-00038.
  • Patel, S. S.; Spencer, C. M. Remifentanil. Drugs 1996, 52, 417–427. DOI: 10.2165/00003495-199652030-00009.
  • Rosow, C. E. An Overview of Remifentanil. Anesth. Analg. 1999, 89, S1–S3. DOI: 10.1097/00000539-199910001-00001.
  • Levine, A. I.; Bryson, E. O. Intranasal Self-Administration of Remifentanil as the Foray into Opioid Abuse by an Anesthesia Resident. Anesth. Analg. 2010, 110, 524–525. DOI: 10.1213/ANE.0b013e3181c5f069.
  • Feldman, P. L.; James, M. K.; Brackeen, M. F.; Johnson, M. R.; Leighton, H. J. US Patent. 5019583, 1991.
  • Cheng, B. K.-M.; Halvachs, R. E. Process for Remifentanil Synthesis. US Patent 2010048908, 2010.
  • Selinger, K.; Lanzo, C.; Sekut, A. Determination of Remifentanil in Human and Dog Blood by HPLC with UV Detection. J. Pharm. Biomed. Anal. 1994, 12, 243–248. DOI: 10.1016/0731-7085(94)90035-3.
  • Haidar, S. H.; Liang, Z.; Selinger, K.; Hamlett, L.; Eddington, N. D. Determination of Remifentanil, an Ultra-Short-Acting Opioid Anesthetic, in Rat Blood by High Performance Liquid Chromatography with Ultraviolet Detection. J. Pharm. Biomed. Anal. 1996, 14, 1727–1732. DOI: 10.1016/0731-7085(96)01831-6.
  • Coopman, V.; Cordonnier, J.; De Leeuw, M.; Cirimele, V. Ocfentanil Overdose Fatality in the Recreational Drug Scene. Forensic Sci. Int. 2016, 266, 469–473. DOI: 10.1016/j.forsciint.2016.07.005.
  • Dussy, F. E.; Hangartner, S.; Hamberg, C.; Berchtold, C.; Scherer, U.; Schlotterbeck, G.; Wyler, D.; Briellmann, T. A. An Acute Ocfentanil Fatality: A Case Report with Postmortem Concentrations. J. Anal. Toxicol. 2016, 40, 761–766. DOI: 10.1093/jat/bkw096.
  • Casati, S.; Minoli, M.; Angeli, I.; Ravelli, A.; Crudele, G. D. L.; Orioli, M. An Ocfentanil‐Related Death Case: UHPLC–MS/MS Analysis of the Drug. Drug Test. Anal. 2019, 11, 173–177. DOI: 10.1002/dta.2473.
  • Klar, S. A.; Brodkin, E.; Gibson, E.; Padhi, S.; Predy, C.; Green, C.; Lee, V. Notes from the Field: Furanyl-Fentanyl Overdose Events Caused by Smoking Contaminated Crack Cocaine—British Columbia, Canada, July 15–18, 2016. Mmwr. Morb. Mortal. Wkly. Rep. 2016, 65, 1015–1016. DOI: 10.15585/mmwr.mm6537a6.
  • Huang, B.-S.; Terrell, R. C.; Deutsche, K. H.; Kudzma, L. V.; Lalinde, N. L. N-Aryl-N-(4-Piperidinyl)Amides and Pharmaceutical Compositions and Method Employing Such Compounds. US Patent 4584303A 1986.
  • Martin, M.; Hecker, J.; Clark, R.; Frye, J.; Jehle, D.; Lucid, E. J.; Harcheiroad, F. China White Epidemic: An Eastern United States Emergency Department Experience. Ann. Emerg. Med. 1991, 70, 158–164. DOI: 10.1016/S0196-0644(05)81216-8.
  • Hibbs, J.; Perper, J.; Winek, C. L. An Outbreak of Designer Drug-Related Deaths in Pennsylvania. JAMA 1991, 265, 1011–1013. DOI: 10.1001/jama.1991.03460080081037.
  • Kram, T. C.; Cooper, D. A.; Allen, A. C. Behind the Identification of China White. Anal. Chem. 1981, 53, 1379A–1386A. DOI: 10.1021/ac00235a790.
  • Henderson, G. L. Fentanyl-Related Deaths: Demographics, Circumstances, and Toxicology of 112 Cases. J. Forensic Sci. 1991, 36, 13045J. DOI: 10.1520/JFS13045J.
  • Vuckovic, S.; Prostran, M.; Ivanovic, M.; Dosen-Micovic, L.; Todorovic, Z.; Nesic, Z.; Stojanovic, R.; Divac, N.; Mikovic, Z. Fentanyl Analogs: Structure-Activity-Relationship Study. CMC. 2009, 16, 2468–2474. DOI: 10.2174/092986709788682074.
  • Henderson, G. L. Designer Drugs: Past History and Future Prospects. J. Forensic Sci. 1988, 33, 11976J. DOI: 10.1520/JFS11976J.
  • Ojanperä, I.; Gergov, M.; Liiv, M.; Riikoja, A.; Vuori, E. An Epidemic of Fatal 3-Methylfentanyl Poisoning in Estonia. Int. J. Legal Med. 2008, 122, 395–400. DOI: 10.1007/s00414-008-0230-x.
  • Ojanperä, I.; Gergov, M.; Rasanen, I.; Lunetta, P.; Toivonen, S.; Tiainen, E.; Vuori, E. Blood Levels of 3-Methylfentanyl in 3 Fatal Poisoning Cases. Am. J. Forensic Med. Pathol. 2006, 27, 328–331. DOI: 10.1097/01.paf.0000188097.78132.e5.
  • Sofalvi, S.; Schueler, H. E.; Lavins, E. S.; Kaspar, C. K.; Brooker, I. T.; Mazzola, C. D.; Dolinak, D.; Gilson, T. P.; Perch, S. An LC–MS-MS Method for the Analysis of Carfentanil, 3-Methylfentanyl, 2-Furanyl Fentanyl, Acetyl Fentanyl, Fentanyl and Norfentanyl in Postmortem and Impaired-Driving Cases. J. Anal. Toxicol. 2017, 41, 473–483. DOI: 10.1093/jat/bkx052.
  • Kanamori, T.; Iwata, Y. T.; Segawa, H.; Yamamuro, T.; Kuwayama, K.; Tsujikawa, K.; Inoue, H. Characterization and Differentiation of Geometric Isomers of 3-Methylfentanyl Analogs by Gas Chromatography/Mass Spectrometry, Liquid Chromatography/Mass Spectrometry, and Nuclear Magnetic Resonance Spectroscopy. J. Forensic Sci. 2017, 62, 1472–1478. DOI: 10.1111/1556-4029.13395.
  • Fogarty, M. F.; Papsun, D. M.; Logan, B. K. Analysis of Cis and Trans 3-Methylfentanyl by Liquid Chromatography-High Resolution Mass Spectrometry and Findings in Forensic Toxicology Casework. Drug Test. Anal. 2018, 10, 1474–1482. DOI: 10.1002/dta.2414.